Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Stapokibart
Mometasone Furoate Nasal Spray (MFNS)
Locations
1
China
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
February 1, 2025
Primary Completion Date
December 1, 2025
Completion Date
July 1, 2026
Last Updated
February 6, 2025
NCT07486401
NCT07323485
NCT07071649
NCT07234695
NCT07125586
NCT06817252
Lead Sponsor
Beijing Tongren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions